香港股市 已收市

邁克生物 (300463.SZ)

Shenzhen - Shenzhen 延遲價格。貨幣為 CNY。
加入追蹤清單
13.68-0.22 (-1.58%)
收市:03:04PM CST

邁克生物

Hi-tech Zone
No. 8, Anhe 2nd Road
Chengdu 611730
China
86 28 8173 1888
https://www.maccura.com

版塊Healthcare
行業Diagnostics & Research
全職員工3,362

高階主管

名稱頭銜支付行使價出生年份
Mr. Wu MingjianGM & Director1977
Ms. Shan YinCFO & Director1981
Ms. Ping YuAdministrative Director & Manager of Human Resource Department1981
Mr. Shengguo XuDirector of Marketing & Director1979
Ms. Wei ShiSecretary & Director of Strategic Investment1975
Ms. Hui YangDirector of Production - Reagents1968
截止 為止計算的金額,現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 CNY。

描述

Maccura Biotechnology Co.Ltd engages in the research, development, manufacture, and sale of IVD products and related services in China and internationally. The company offers immunoassay products, such as chemiluminescence analyzers and reagents; clinical chemistry reagents for hepatic function, glycometabolism, iron and other, renal function, coagulation, special protein, cardiac, and lipids; and clinical laboratory products, such as automatic hematology, and automatic and semi-automatic coagulation analyzers. It provides SARS-COV-2(COVID-19) products that includes nucleic acid detection kit and other products; glucometers; POCT products, such as fluorescence immunoassay analyzers, as well as colloidal gold kits; molecular diagnosis products, such as PCR kit; and pathology products. Maccura Biotechnology Co.Ltd was incorporated in 1994 and is based in Chengdu, China.

公司管治

截至 無 止,邁克生物 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中:無;董事會:無;股東權利:無;現金賠償:無。

企業管治評分的資料提供: Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險,而 10 分表示較高的管治風險。